LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermometer-Like Device Could Help Diagnose Heart Attacks

By LabMedica International staff writers
Posted on 18 May 2015
Print article
Image: Schematic illustration of the detection of Troponin 1 using glass vials and capillary tubes with an ink indicator (Photo courtesy of the American Chemical Society).
Image: Schematic illustration of the detection of Troponin 1 using glass vials and capillary tubes with an ink indicator (Photo courtesy of the American Chemical Society).
Diagnosing a heart attack can require multiple tests using expensive equipment, but not everyone has access to such techniques, especially in remote or low-income areas.

A simple device has been developed that could help doctors diagnose heart attacks with minimal materials and cost that uses a basic but sensitive method for measuring troponin concentrations using an alcohol thermometer-like glass vial and dendritic platinum nanoparticles.

Chemical engineers at the Pohang University of Science and Technology (Republic of Korea) developed a device that detects Troponin 1 (TnI) using an antibody-functionalized glass vial and a capillary tube containing a drop of safranin ink in an aqueous solution. A solution of antibody-functionalized platinum (Pt) nanoparticles was added to of TnI-spiked human serum. After incubation for 10 minutes at room temperature with gentle shaking, the sample containing TnI–Pt complexes was added to a gastight glass vial whose inner surfaces were coated with TnI antibodies.

The captured TnI was conjugated to the inner surface of a glass vial, to which a hydrogen peroxide (H2O2) solution was added. After the glass vial was sealed with a screw cap containing a silicon septum, a capillary tube containing a drop of ink was inserted through the septum. The catalytic dissociation of H2O2 to water and oxygen increased the pressure inside the glass vial and raised the ink level in the capillary tube. The ink level increased with the platinum nanoparticle concentration, which is proportional to the TnI concentration. The sensitivity of this assay for TnI in human serum after a five minute dissociation reaction, detected with the naked eye, was 0.1 ng/mL, which was better than the sensitivity of the conventional colorimetric method using the 3,5,3',5'-Tetramethylbenzidine (TMB) oxidation reaction under the same conditions.

The authors concluded that they had successfully developed an adroit method for the detection of TnI in human serum using antibody-functionalized dendritic platinum nanoparticles and a capillary tube containing a drop of ink. The pressure increase caused by the catalytic dissociation of H2O2 by platinum nanoparticles induces an increase in ink level, which is easily identified with the naked eye. Because the ink level increases further with reaction time, the limit of detection could be improved by increasing the reaction time. This simple and cost-effective method may be especially beneficial for people in underdeveloped countries. The study was published on April 20, 2015, in the journal Analytical Chemistry.

Related Links:

Pohang University of Science and Technology


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.